Critical Comparison: Carl Zeiss Meditec (OTCMKTS:CZMWY) and InfuSystem (NYSE:INFU)

Carl Zeiss Meditec (OTCMKTS:CZMWY) and InfuSystem (NYSE:INFU) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk.

Earnings and Valuation

This table compares Carl Zeiss Meditec and InfuSystem”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carl Zeiss Meditec	N/A	N/A	N/A	$0.92	85.53
InfuSystem	$129.37 million	1.11	$870,000.00	$0.00	-675,000.00

InfuSystem has higher revenue and earnings than Carl Zeiss Meditec. InfuSystem is trading at a lower price-to-earnings ratio than Carl Zeiss Meditec, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

0.1% of Carl Zeiss Meditec shares are held by institutional investors. Comparatively, 71.1% of InfuSystem shares are held by institutional investors. 10.2% of InfuSystem shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Carl Zeiss Meditec and InfuSystem’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Carl Zeiss Meditec	N/A	N/A	N/A
InfuSystem	0.28%	0.70%	0.35%

Analyst Recommendations

This is a summary of recent recommendations for Carl Zeiss Meditec and InfuSystem, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carl Zeiss Meditec	0	0	0	0	N/A
InfuSystem	0	0	0	2	4.00

InfuSystem has a consensus price target of $13.00, indicating a potential upside of 92.59%. Given InfuSystem’s higher probable upside, analysts plainly believe InfuSystem is more favorable than Carl Zeiss Meditec.

Summary

InfuSystem beats Carl Zeiss Meditec on 8 of the 10 factors compared between the two stocks.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

About InfuSystem

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.